| Literature DB >> 35915491 |
Sikiru Baruwa1, Elizabeth Tobey2, Emeka Okafor3, Kayode Afolabi4, Toyin O Akomolafe5, Innocent Ubuane5, Jennifer Anyanti3, Aparna Jain2.
Abstract
BACKGROUND: CPs and PPMVs are an important source of modern contraceptives in Nigeria, yet many lack the requisite knowledge and skills to capably provide these services. This skills gap might be addressed through targeted family planning (FP) training. This study measures family planning knowledge retention of CPs and PPMVs after receiving training in FP counseling and services in Kaduna and Lagos States, in Nigeria.Entities:
Keywords: Community pharmacists; FP jobs aids; FP knowledge; Knowledge of implant contraceptives; Knowledge of injectable contraceptives; Knowledge retention; PPMVs; Task shifting and task sharing
Mesh:
Substances:
Year: 2022 PMID: 35915491 PMCID: PMC9340708 DOI: 10.1186/s12913-022-08360-0
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.908
Tiered Accreditation Training
| ELIGIBILITY CRITERIA | SCOPE OF WORK (Pharmaceutical care and Service Delivery) | |
|---|---|---|
1. Ability to read and write. 2. Attainment of 21 years of age. 3. Qualified personnel will include those who attempted to obtain a First School Leaving Certificate. 4. Also, in this category are Bachelor’s degree in biological sciences or any other disciplines (outside of health related disciplines | 1. Sell OTC and manage common illnesses. 2. FP services will include condoms, cycle beads, emergency contraceptives, refill of pills but not initiation, counselling, and referrals. 3. However, persons who have training on the use of malaria rapid diagnostic test-kits (m RDT) may use the test kits to test patients for malaria. | |
1. Must fulfil the tier 1 eligibility criteria. 2. In addition, must possess degree in Health discipline as recognized by the Pharmacists Council of Nigeria 3. They could be Nurses, Midwives, CHEWs, CHOs | 1. Provide select PHC services in line with the 2. Provide tier 1 services as well as use Rapid Diagnostic Test kits (RDTs), administer amoxicillin DT, conduct HIV Self Testing, sell self-injecting contraceptives and refer patients to PHCs and higher level facilities for nutrition counselling and treatment of any other common ailment. 3. They will also be allowed to initiate and administer LARC particularly implants if they have received training on comprehensive FP services in line with the Task Shifting and Task sharing policy. | |
1. These persons must fulfill the tier 1 eligibility criteria. 2. Must be Pharmacy technician | 1. PPMV operators in this tier will be enabled to provide selected PHC services 2. They will provide tier 1 services as well as use Rapid Diagnostic Test kits (RDTs), administer amoxicillin DT, conduct HIV Self Testing if trained 3. Sell self-injecting contraceptives and refer patients to PHCs and higher level facilities for nutrition counselling and treatment of any other common ailment |
Job Aids Given to Providers under IntegratE Project
| Type of Job Aid | Description | Providers who received job aids |
|---|---|---|
| BCS+ counseling cards | It consists of information on pregnancy checklist, FP methods (use, side effects and duration), and information on HIV risk assessment, counseling, and testing | All providers |
| BCS+ Algorithm | Algorithm provides steps and questions to ask in the Pre-Choice Stage, Method Choice Stage, Post-Choice Stage. It also offers systematic screening of STIs /HIV including Prevention, Risk Assessment, and Counseling and Testing Stage. | All providers |
| FP Flip Chart | The FP Flip Chart contains information about FP methods (short-term, long-term, and permanent use), information on advantages and disadvantages for each method, possible side effects for each method, how to conduct counseling, HIV information, and pregnancy checklist. | All providers |
| FP method brochures | Pamphlets and leaflets on methods including their effectiveness, general information, how method works, important facts, side effects, how to use, and next steps. | All providers |
| MEC Wheel Check list | This wheel contains the medical eligibility criteria for starting use of contraceptive methods. It guides family planning providers in recommending safe and effective contraception methods for women with medical conditions or medically-relevant. Characteristics. The wheel includes recommendations on initiating use of nine common types of contraceptive methods. | Tier 2 PPMVs, Tier 3 PPMVs and CPs |
Background Characteristics of Private Providers in IntegratE Project Evaluation by Total and Provider Type, at Pretest
| CPs ( | Tier 2 PPMVs ( | Tier 1 PPMVs ( | Total ( | |
|---|---|---|---|---|
| Male | 47.8 | 30.0 | 33.8 | 39.2 |
| Female | 52.2 | 70.0 | 62.2 | 60.3 |
| 21–29 | 11.8 | 19.2 | 12.2 | 14.7 |
| 30–39 | 33.5 | 43.7 | 28.4 | 36.7 |
| 40–49 | 25.7 | 21.6 | 44.6 | 26.7 |
| 50+ | 24.6 | 14.1 | 14.9 | 19.3 |
| Lagos | 72.8 | 7.0 | 51.4 | 44.9 |
| Kaduna | 27.2 | 93.0 | 48.6 | 55.1 |
| No | 4.8 | 15.0 | 50.0 | 14.7 |
| Yes | 91.9 | 85.0 | 45.9 | 83.2 |
| Never | 54.0 | 47.9 | 48.6 | 51.0 |
| Within the past month | 0.4 | 0.9 | 4.1 | 1.1 |
| 2–6 months ago | 2.6 | 4.7 | 12.2 | 4.7 |
| 7–12 months ago | 4.0 | 7.0 | 2.7 | 5.0 |
| Over 1 year ago | 34.2 | 38.5 | 31.1 | 35.4 |
Knowledge retention of FP from posttest to 9 months among CPs, Tier 1 PPMVs and Tier 2 PPMVs (n = 559)
| Posttest ( | 9-months later, among those that answered correctly at posttest | |
|---|---|---|
| ( | ||
| OCPs, implant, ECP (incorrect) | 2.0 | 0.5 |
| Condoms (correct) | 98.0 | 99.5 |
| ( | ||
| Incorrect | 40.6 | 13.0 |
| Correct | 57.8 | 87.0 |
| ( | ||
| Incorrect | 75.5 | 75.9 |
| Correct | 24.5 | 24.1 |
| ( | ||
| Incorrect | 73.0 | 81.5 |
| Correct | 27.0 | 18.5 |
| ( | ||
| Incorrect | 10.4 | 12.6 |
| Correct | 89.6 | 87.4 |
| ( | ||
| Incorrect | 10.2 | 4.2 |
| Correct | 89.8 | 95.8 |
| ( | ||
| Incorrect | 51.7 | 48.5 |
| Correct | 48.3 | 51.5 |
| ( | ||
| Incorrect | 13.1 | 6.8 |
| Correct | 86.9 | 93.2 |
| ( | ||
| Incorrect | 44.2 | 5.8 |
| Correct | 55.8 | 94.2 |
| ( | ||
| Incorrect | 25.8 | 15.1 |
| Correct | 72.5 | 84.9 |
| ( | ||
| Incorrect | 39.4 | 49.0 |
| Correct | 60.6 | 51.0 |
Knowledge of injectable contraceptives retention from posttest to 9 months among CPs and Tier 2 PPMVs (n = 485)
| Posttest ( | 9 months later, among those that answered correctly at posttest | |
|---|---|---|
| ( | ||
| Incorrect | 12.2 | 7.9 |
| Correct | 86.6 | 92.1 |
| ( | ||
| Incorrect | 7.0 | 15.7 |
| Correct | 93.0 | 84.3 |
| ( | ||
| Incorrect | 20.6 | 19.5 |
| Correct | 79.4 | 80.5 |
| ( | ||
| Incorrect | 5.2 | 3.5 |
| Correct | 94.8 | 96.5 |
| ( | ||
| Incorrect | 8.7 | 4.9 |
| Correct | 88.5 | 95.1 |
| ( | ||
| Incorrect | 9.1 | 9.3 |
| Correct | 90.9 | 90.7 |
| ( | ||
| Incorrect | 44.7 | 48.1 |
| Correct | 53.6 | 51.9 |
| ( | ||
| Incorrect | 14.2 | 9.6 |
| Correct | 85.8 | 90.4 |
| ( | ||
| Incorrect | 11.5 | 4.2 |
| Correct | 88.5 | 95.8 |
| ( | ||
| Incorrect | 57.7 | 17.6 |
| Correct | 42.3 | 82.4 |
| ( | ||
| Incorrect | 4.7 | 7.1 |
| Correct | 92.4 | 92.9 |
Knowledge of implant contraceptives retention from posttest to 9 months among CPs and Tier 2 PPMVs (n = 485)
| Posttest ( | 9 months later, among those that answered correctly at posttest | |
|---|---|---|
| ( | ||
| Incorrect | 74.8 | 92.4 |
| Correct | 21.6 | 7.6 |
| ( | ||
| Incorrect | 17.7 | 25.3 |
| Correct | 82.3 | 74.7 |
| ( | ||
| Incorrect | 4.1 | 0.4 |
| Correct | 95.9 | 99.6 |
| ( | ||
| Incorrect | 21.6 | 22.7 |
| Correct | 74.4 | 77.3 |
| ( | ||
| Incorrect | 53.6 | 66.7 |
| Correct | 46.4 | 33.3 |
| ( | ||
| Incorrect | 38.8 | 33.0 |
| Correct | 61.2 | 67.0 |
| ( | ||
| Incorrect | 12.8 | 24.2 |
| Correct | 82.7 | 75.8 |
aFirst step is to decontaminate in chlorine solution before this process
Bivariate results of FP, injectable and implement knowledge retention 9-months later by jobs aids and respondent characteristics
| FP knowledge retention | Knowledge of injectable contraceptives retention | Knowledge of implant contraceptives retention | ||||
|---|---|---|---|---|---|---|
| % | n | % | n | % | n | |
| Did not receive | 59.6 | 52 | 58.1 | 43 | 34.9** | 43 |
| Received | 57.6 | 507 | 64.5 | 442 | 59.5 | 442 |
| Did not receive | 59.7 | 288 | 62.2 | 233 | 62.2 | 233 |
| Received | 55.9 | 270 | 65.3 | 251 | 53.0 | 251 |
| Did not receive | 52.3 | 151 | 57.8 | 83 | 42.2** | 83 |
| Received | 59.8 | 408 | 65.2 | 402 | 60.5 | 402 |
| Male | 58.0 | 219 | 55.7** | 194 | 53.6 | 194 |
| Female | 58.2 | 337 | 69.4 | 291 | 59.8 | 291 |
| 21–29 | 57.3 | 82 | 64.4 | 73 | 63.0 | 73 |
| 30–39 | 56.1 | 205 | 60.3 | 184 | 57.6 | 184 |
| 40–49 | 54.4 | 149 | 69.0 | 116 | 59.5 | 116 |
| 50+ | 63.9 | 108 | 63.9 | 97 | 49.5 | 97 |
| CP | 77.2** | 272 | 58.1** | 272 | 57.7 | 272 |
| Tier 2 PPMV | 41.3 | 213 | 71.4 | 213 | 56.8 | 213 |
| Tier 1 PPMV | 33.8 | 74 | – | – | – | |
| Kaduna | 50.0** | 308 | 67.3 | 272 | 62.1 | 272 |
| Lagos | 67.3 | 251 | 59.6 | 213 | 51.2 | 213 |
| No | 30.5** | 82 | 53.3 | 45 | 60.0 | 45 |
| Yes | 62.2 | 465 | 65.0 | 431 | 57.3 | 431 |
| No | – | – | 55.0** | 180 | – | – |
| Yes | – | – | 69.2 | 305 | – | – |
| No | – | – | – | – | 57.3 | 368 |
| Yes | – | – | – | – | 57.3 | 117 |
* p-value ≤ 0.05; ** p-value ≤ 0.01
Adjusted odds ratios of FP, injectable and implement knowledge retention 9-months later
| FP knowledge retention ( | Knowledge of injectable contraceptives retention ( | Knowledge of implant contraceptives retention ( | ||||
|---|---|---|---|---|---|---|
| AOR | 95% CI | AOR | 95% CI | AOR | 95% CI | |
| Did not receive | ref | ref | ref | |||
| Received | 2.92* | 1.01–8.40 | 1.01 | 0.32–3.21 | 1.14 | 0.36–3.60 |
| Did not receive | ref | ref | ref | |||
| Received | 0.85 | 0.57–1.27 | 1.07 | 0.71–1.60 | 0.38** | 0.25–0.57 |
| Did not receive | ref | ref | ref | |||
| Received | 1.20 | 0.63–2.27 | 2.13* | 1.14–3.99 | 2.24* | 1.17–4.28 |
| Male | ref | ref | ref | |||
| Female | 1.43 | 0.96–2.13 | 1.74** | 1.17–2.59 | 1.48* | 1.0–2.21 |
| 21–29 | ref | ref | ref | |||
| 30–39 | 0.88 | 0.50–1.55 | 0.86 | 0.48–1.54 | 0.91 | 0.51–1.62 |
| 40–49 | 0.78 | 0.43–1.43 | 1.41 | 0.74–2.71 | 0.94 | 0.50–1.77 |
| 50+ | 1.04 | 0.54–2.02 | 1.15 | 0.59–2.25 | 0.72 | 0.37–1.40 |
| CP | 5.68** | 3.25–9.92 | 0.66 | 0.37–1.19 | 1.90* | 1.07–3.39 |
| Tier 2 PPMV | ref | ref | ref | |||
| Tier 1 PPMV | 1.33 | 0.58–3.05 | – | – | – | – |
| Kaduna | ref | ref | ref | |||
| Lagos | 0.76 | 0.45–1.28 | 0.96 | 0.57–1.62 | 0.38** | 0.22–0.65 |
| No | ref | ref | ref | |||
| Yes | 2.22** | 1.25–3.94 | 2.00* | 1.04–3.87 | 0.88 | 0.45–1.71 |
| No | – | – | ref | – | – | |
| Yes | – | – | 1.48 | 0.94–2.33 | – | – |
| No | – | – | – | – | ref | – |
| Yes | – | – | – | – | 0.89 | 0.54–1.47 |
* p-value ≤0.05; ** p-value ≤0.01